Both in Pharmaceuticals
Faeth Therapeutics vs Crescent Biopharma
Over the past year FTH returned −50.1% and CBIO returned −30.6%; their daily moves had a correlation of 0.54.
FTH −50.1% CBIO −30.6%Growth of $1, one year, split-adjusted
| Metric | FTH | CBIO |
|---|---|---|
| Price | $18.69 | $13.48 |
| Market cap | $483.0M | $500.7M |
| Today | −0.32% | −4.19% |
| 1 month | −33.9% | −5.5% |
| 6 months | — | −25.4% |
| Year to date | — | +13.7% |
| 1 year | — | +7.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 42.1× |
| Net cash | $186.4M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 68.9% |
| Short % of float | 16.6% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).